Lab study: New gold nanoparticle lithium delivery for bipolar disorder
Part of Mental health clinical trials.
This study tests a new way to deliver lithium using tiny gold particles in laboratory models. It may lead to a safer form of treatment for people with bipolar disorder, but this trial is not recruiting patients yet—it's being done in the lab.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a diagnosis of Bipolar I or Bipolar II disorder.
- You have never taken lithium before.
- You have not taken any psychiatric medications in the past 12 months (except occasional low-dose sleep or anxiety pills).
- You do not have active suicidal thoughts with a plan or intent.
- You are medically stable and have no major health conditions like liver, kidney, or heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how lithium works in everyday life for people with bipolar disorder. It aims to learn about real-world treatment patterns and outcomes.
This trial tests a new medical device that uses a blood test to help doctors accurately diagnose bipolar disorder in people who were thought to have major depression. It aims to see if the device can tell the difference and improve treatment choices.
This trial uses brain organoids (tiny lab-grown cell clusters) to study how brain development differs in people with bipolar disorder, especially those with early developmental signs. It aims to find markers that could help diagnose or treat the condition earlier.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This study compares a new lithium capsule (AL001) to a standard lithium capsule in people with Bipolar I Disorder. It aims to see how well your body absorbs each capsule and whether AL001 is safer or more tolerable.
This study looks at how lithium, a common mood-stabilizing medication, works in the brain. It uses brain scans and aims to understand how the drug affects mood and sleep. You must be healthy (no mental health conditions) and not taking other medications.
Hear when a new Bipolar Disorder (BD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.